These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22969220)

  • 1. Entry of hepatitis C virus into the cell: a therapeutic target.
    Del Campo JA; Rojas Á; Romero-Gómez M
    World J Gastroenterol; 2012 Sep; 18(33):4481-5. PubMed ID: 22969220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor.
    Sainz B; Barretto N; Martin DN; Hiraga N; Imamura M; Hussain S; Marsh KA; Yu X; Chayama K; Alrefai WA; Uprichard SL
    Nat Med; 2012 Jan; 18(2):281-5. PubMed ID: 22231557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection.
    Bocchetta S; Maillard P; Yamamoto M; Gondeau C; Douam F; Lebreton S; Lagaye S; Pol S; Helle F; Plengpanich W; Guérin M; Bourgine M; Michel ML; Lavillette D; Roingeard P; le Goff W; Budkowska A
    PLoS One; 2014; 9(3):e92140. PubMed ID: 24646941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus may have an entero-hepatic cycle which could be blocked with ezetimibe.
    Monrroy H; López-Lastra M; Soza A
    Med Hypotheses; 2017 May; 102():51-55. PubMed ID: 28478831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezetimibe inhibits dengue virus infection in Huh-7 cells by blocking the cholesterol transporter Niemann-Pick C1-like 1 receptor.
    Osuna-Ramos JF; Reyes-Ruiz JM; Bautista-Carbajal P; Cervantes-Salazar M; Farfan-Morales CN; De Jesús-González LA; Hurtado-Monzón AM; Del Ángel RM
    Antiviral Res; 2018 Dec; 160():151-164. PubMed ID: 30391500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Niemann-Pick-type C1-like1 by ezetimibe activates autophagy in human hepatocytes and reduces mutant α1-antitrypsin Z deposition.
    Yamamura T; Ohsaki Y; Suzuki M; Shinohara Y; Tatematsu T; Cheng J; Okada M; Ohmiya N; Hirooka Y; Goto H; Fujimoto T
    Hepatology; 2014 Apr; 59(4):1591-9. PubMed ID: 24214142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
    Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
    Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Niemann-Pick C1 like 1 (NPC1L1) inhibitor ezetimibe improves metabolic disease via decreased liver X receptor (LXR) activity in liver of obese male mice.
    Sugizaki T; Watanabe M; Horai Y; Kaneko-Iwasaki N; Arita E; Miyazaki T; Morimoto K; Honda A; Irie J; Itoh H
    Endocrinology; 2014 Aug; 155(8):2810-9. PubMed ID: 24773344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic background of the efficacy of cholesterol absorption. The role of Niemann-Pick C1-like 1 receptor and its genetic variations in lipid metabolism].
    Harangi M; Balogh I; Harangi J; Paragh G
    Orv Hetil; 2010 Aug; 151(34):1376-83. PubMed ID: 20705552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes.
    Lucifora J; Esser K; Protzer U
    Antiviral Res; 2013 Feb; 97(2):195-7. PubMed ID: 23266293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niemann-Pick C1-Like 1 and cholesterol uptake.
    Wang LJ; Song BL
    Biochim Biophys Acta; 2012 Jul; 1821(7):964-72. PubMed ID: 22480541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ezetimibe restores biliary cholesterol excretion in mice expressing Niemann-Pick C1-Like 1 only in liver.
    Tang W; Jia L; Ma Y; Xie P; Haywood J; Dawson PA; Li J; Yu L
    Biochim Biophys Acta; 2011 Sep; 1811(9):549-55. PubMed ID: 21683156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezetimibe, a selective inhibitor of the transport of cholesterol.
    Miura S; Saku K
    Intern Med; 2008; 47(13):1165-70. PubMed ID: 18591835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel role of NPC1L1 in the regulation of hepatic metabolism: potential contribution of ezetimibe in NAFLD/NASH treatment.
    Yoshida M
    Curr Vasc Pharmacol; 2011 Jan; 9(1):121-3. PubMed ID: 21044016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ezetimibe interferes with cholesterol trafficking from the plasma membrane to the endoplasmic reticulum in CaCo-2 cells.
    Field FJ; Watt K; Mathur SN
    J Lipid Res; 2007 Aug; 48(8):1735-45. PubMed ID: 17473178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.
    Liu S; McCormick KD; Zhao W; Zhao T; Fan D; Wang T
    Hepatology; 2012 Aug; 56(2):484-91. PubMed ID: 22334503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo responsiveness to ezetimibe correlates with niemann-pick C1 like-1 (NPC1L1) binding affinity: Comparison of multiple species NPC1L1 orthologs.
    Hawes BE; O'neill KA; Yao X; Crona JH; Davis HR; Graziano MP; Altmann SW
    Mol Pharmacol; 2007 Jan; 71(1):19-29. PubMed ID: 17005902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes.
    Verrier ER; Colpitts CC; Bach C; Heydmann L; Zona L; Xiao F; Thumann C; Crouchet E; Gaudin R; Sureau C; Cosset FL; McKeating JA; Pessaux P; Hoshida Y; Schuster C; Zeisel MB; Baumert TF
    Cell Rep; 2016 Oct; 17(5):1357-1368. PubMed ID: 27783949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple plasma membrane receptors but not NPC1L1 mediate high-affinity, ezetimibe-sensitive cholesterol uptake into the intestinal brush border membrane.
    Knöpfel M; Davies JP; Duong PT; Kvaernø L; Carreira EM; Phillips MC; Ioannou YA; Hauser H
    Biochim Biophys Acta; 2007 Sep; 1771(9):1140-7. PubMed ID: 17689140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV Infectivity.
    Zapatero-Belinchón FJ; Ötjengerdes R; Sheldon J; Schulte B; Carriquí-Madroñal B; Brogden G; Arroyo-Fernández LM; Vondran FWR; Maasoumy B; von Hahn T; Gerold G
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.